SLC38A3: Solute Carrier Family 38 Member 3

Sodium-coupled neutral amino acid transporter 3 (SNAT3) – key glutamine transporter in brain and liver

Gene Information Card

Symbol SLC38A3
Full Name solute carrier family 38 member 3
Gene Type protein-coding
Chromosomal Location 3p21.31
NCBI Gene ID 10991 ncbi.nlm.nih.gov/gene/10991
Ensembl ID ENSG00000114544
UniProt ID Q99624
OMIM ID 604437
HGNC ID 10946
Aliases SNAT3, G17, NAT1

Description

SLC38A3 encodes SNAT3 (sodium-coupled neutral amino acid transporter 3), a member of the SLC38 family. It mediates the sodium-dependent transport of neutral amino acids, particularly glutamine, with high affinity. SNAT3 is expressed predominantly in brain (astrocytes) and liver, where it plays a critical role in glutamine-glutamate cycling and hepatic urea synthesis. The transporter is bidirectional and can also function in efflux mode under certain conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatic encephalopathy Impaired glutamine transport in astrocytes leads to ammonia accumulation and brain edema PMID: 19265428
Glutamine deficiency / metabolic disorders Reduced SLC38A3 activity disrupts nitrogen shuttling between tissues PMID: 21715563
Cancer (glioma, hepatocellular carcinoma) Altered glutamine uptake supports tumor growth and proliferation PMID: 25642768

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 High
Liver 8.3 Medium
Kidney 4.1 Low
Pancreas 2.0 Low
Skeletal muscle 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
U-87 MG (glioblastoma) 15.2 High expression
HepG2 (hepatocellular carcinoma) 9.8 Moderate expression
HEK293 (embryonic kidney) 3.5 Low expression
A549 (lung carcinoma) 1.2 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.104C>T (p.Pro35Leu) Missense <0.01% Unknown functional effect
c.457G>A (p.Gly153Ser) Missense <0.01% Reduced glutamine transport activity (in vitro)
c.1120A>G (p.Thr374Ala) Missense <0.01% No significant effect
Mutation functional classification

Loss of Function (LOF)

p.Gly153Ser reduces glutamine uptake in heterologous expression systems.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported.

Pathways

REACT:116909 – Transport of glucose and other sugars
bile salts and organic acids
metal ions and amine compounds
REACT:111045 – Amino acid transport across the plasma membrane
WP:WP822 – Glutamine metabolism
WP:WP364 – Urea cycle and metabolism of amino groups

Protein Summary

SNAT3 is a 504-amino acid transmembrane protein with 11 predicted membrane-spanning domains. It functions as a sodium-coupled symporter for neutral amino acids, with highest affinity for glutamine (Km ~0.5 mM). The protein is localized to the plasma membrane and is expressed in astrocytes, hepatocytes, and renal tubules. SNAT3 plays a key role in the glutamine-glutamate cycle in the brain and in hepatic nitrogen metabolism. Its expression is regulated by ammonia and pH, and it is implicated in cancer cell metabolism.

Related Products

Product name Cat.No. Species Gene ID
SLC38A3 Knockout HEK293 Cell Line EDJ-KQ7236 Human 10991 Details Get a Quote
SLC38A3 Knockout HCT 116 Cell Line EDJ-KQ32215 Human 10991 Details Get a Quote
SLC38A3 Knockout HeLa Cell Line EDJ-KQ55539 Human 10991 Details Get a Quote
SLC38A3 Knockout A-549 Cell Line EDJ-KQ64032 Human 10991 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: